Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Alzheimer's Disease

  Free Subscription


22.01.2018

2 Alzheimer Dis Assoc Disord
3 Alzheimers Dement
1 Ann Neurol
1 Biol Psychiatry
1 BMC Neurol
8 J Alzheimers Dis
1 J Neurol Neurosurg Psychiatry
1 J Neurosci
3 Neurobiol Aging
4 Neurology
1 Neurosci Lett
2 Neuroscience
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. GABEL M, Gooblar J, Roe CM, Selsor NJ, et al
    Political Ideology, Confidence in Science, and Participation in Alzheimer Disease Research Studies.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000244.
    PubMed     Text format     Abstract available

  2. MILAN-TOMAS A, Shapiro CM
    Circadian Rhythms Disturbances in Alzheimer Disease: Current Concepts, Diagnosis, and Management.
    Alzheimer Dis Assoc Disord. 2018 Jan 18. doi: 10.1097/WAD.0000000000000243.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  3. HAMPEL H, Toschi N, Baldacci F, Zetterberg H, et al
    Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Abeta1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33872.
    PubMed     Text format     Abstract available

  4. DI GUARDO G
    Alzheimer's disease, cellular prion protein, and dolphins.
    Alzheimers Dement. 2018 Jan 15. pii: S1552-5260(17)33873.
    PubMed     Text format    

  5. TSE KH, Cheng A, Ma F, Herrup K, et al
    DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's and dementia.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33853.
    PubMed     Text format     Abstract available


    Ann Neurol

  6. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    [(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.
    Ann Neurol. 2018 Jan 11. doi: 10.1002/ana.25142.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  7. STRITTMATTER SM
    Emerging Mechanisms in Alzheimer's Disease and Their Therapeutic Implications.
    Biol Psychiatry. 2018;83:298-299.
    PubMed     Text format    


    BMC Neurol

  8. HUANG X, Liu H, Li X, Guan L, et al
    Revealing Alzheimer's disease genes spectrum in the whole-genome by machine learning.
    BMC Neurol. 2018;18:5.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  9. FAN Y, Luo R, Su LY, Xiang Q, et al
    Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research?
    J Alzheimers Dis. 2018;61:1015-1028.
    PubMed     Text format     Abstract available

  10. SNIR JA, Suchy M, Bindseil GA, Kovacs M, et al
    An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018;61:1241-1252.
    PubMed     Text format     Abstract available

  11. LIU G, Zhang Y, Wang L, Xu J, et al
    Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.
    J Alzheimers Dis. 2018;61:1077-1088.
    PubMed     Text format     Abstract available

  12. HEMACHANDRA REDDY P, Manczak M, Yin X, Grady MC, et al
    Protective Effects of Indian Spice Curcumin Against Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:843-866.
    PubMed     Text format     Abstract available

  13. ROZZINI L, Lanfranchi F, Pilotto A, Catalani S, et al
    Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
    J Alzheimers Dis. 2018;61:907-912.
    PubMed     Text format     Abstract available

  14. TAKENOSHITA S, Terada S, Yokota O, Kutoku Y, et al
    Sally-Anne Test in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018;61:1029-1036.
    PubMed     Text format     Abstract available

  15. CHIZIANE E, Telemann H, Krueger M, Adler J, et al
    Free Heme and Amyloid-beta: A Fatal Liaison in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:963-984.
    PubMed     Text format     Abstract available

  16. JONVEAUX TR, Fescharek R
    When Art Meets Gardens: Does It Enhance the Benefits? The Nancy Hypothesis of Care for Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:885-898.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  17. BOUSIGES O, Bombois S, Schraen S, Wallon D, et al
    Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
    J Neurol Neurosurg Psychiatry. 2018 Jan 10. pii: jnnp-2017-316385.
    PubMed     Text format     Abstract available


    J Neurosci

  18. MUELLER MC, Baranowski BJ, Hayward GC
    New Insights on the Role of Residue 673 of APP in Alzheimer's Disease.
    J Neurosci. 2018;38:515-517.
    PubMed     Text format    


    Neurobiol Aging

  19. SYAMA A, Sen S, Kota LN, Viswanath B, et al
    Mutation burden profile in familial Alzheimer's disease cases from India.
    Neurobiol Aging. 2017 Dec 12. pii: S0197-4580(17)30396.
    PubMed     Text format     Abstract available

  20. BIGNANTE EA, Ponce NE, Heredia F, Musso J, et al
    APP/Go protein Gbetagamma-complex signaling mediates Abeta degeneration and cognitive impairment in Alzheimer's disease models.
    Neurobiol Aging. 2017;64:44-57.
    PubMed     Text format     Abstract available

  21. CANTERO JL, Atienza M, Sanchez-Juan P, Rodriguez-Rodriguez E, et al
    Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.
    Neurobiol Aging. 2017;64:58-67.
    PubMed     Text format     Abstract available


    Neurology

  22. PIAZZA F
    Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2018;90:144-145.
    PubMed     Text format    

  23. KARAM C, Griggs RC
    Editors' note: A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2018;90:144.
    PubMed     Text format    

  24. AISEN PS
    Author response: A phase 3 trial of IV immunoglobulin for Alzheimer disease.
    Neurology. 2018;90:145.
    PubMed     Text format    

  25. MATTSSON N, Smith R, Strandberg O, Palmqvist S, et al
    Comparing (18)F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.
    Neurology. 2018 Jan 10. pii: WNL.0000000000004887.
    PubMed     Text format     Abstract available


    Neurosci Lett

  26. NAGATA K, Mano T, Murayama S, Saido TC, et al
    DNA methylation level of the neprilysin promoter in Alzheimer's disease brains.
    Neurosci Lett. 2018 Jan 12. pii: S0304-3940(18)30003.
    PubMed     Text format     Abstract available


    Neuroscience

  27. OMTRI RS, Thompson K, Tang X, Gali CC, et al
    Differential Effects of Alzheimer's Disease Abeta40 and 42 on Endocytosis and Intraneuronal Trafficking.
    Neuroscience. 2018 Jan 11. pii: S0306-4522(18)30019.
    PubMed     Text format     Abstract available

  28. NYARKO JNK, Quartey MO, Pennington PR, Heistad RM, et al
    Profiles of beta-amyloid peptides and key secretases in brain autopsy samples differ with sex and APOE epsilon4 status: impact for risk and progression of Alzheimer disease.
    Neuroscience. 2018 Jan 10. pii: S0306-4522(18)30021.
    PubMed     Text format     Abstract available


    PLoS One

  29. HA S, Kim I, Takata T, Kinouchi T, et al
    Identification of -amino acid-containing peptides in human serum.
    PLoS One. 2017;12:e0189972.
    PubMed     Text format     Abstract available

  30. MASTROENI D, Sekar S, Nolz J, Delvaux E, et al
    Correction: ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.
    PLoS One. 2018;13:e0191382.
    PubMed     Text format     Abstract available

  31. HAIGHT T, Bryan RN, Meirelles O, Tracy R, et al
    Associations of plasma clusterin and Alzheimer's disease-related MRI markers in adults at mid-life: The CARDIA Brain MRI sub-study.
    PLoS One. 2018;13:e0190478.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: